Arteriovenous Malformations
Conditions
Brief summary
A randomized trial which compares conservative management to progesterone based treatment for arteriovenous malformation
Interventions
DRUGMedroxyPROGESTERone Injection [Depo-Provera]
The drug-induced endometrial changes would likely to prevent the shedding of endometrium, in turn preventing the exposure of AVM.
DEVICEOther
Follow up using US
Sponsors
HaEmek Medical Center, Israel
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* women between age of 18 to 50, diagnosed with AVM * hemodynamically stable at clinical presentation
Exclusion criteria
* unstable patients * contraindication to treatment * US examination not in the US department
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| AVM regression | 3 weeks | The time from diagnosis to regression |
Outcome results
None listed